Release Therapeutics
Release Therapeutics is a privately-held company developing the first cell macroencapsulated cell platform technology designed to deliver potent therapeutic proteins beyond the human blood-brain barrier. The company’s lead program is in preclinical development for the treatment of Metachromatic Leukodystrophy (MLD), a rare genetic disorder that leads to progressive loss of myelin and typically affects young children.
Date, time and room information
May 6, 16:15 - 16:30, room Singapore
Category
Emerging biotech company
Title of the presentation
Empowering patients with genetic CNS disorders to reclaim their lives, without gene therapy
Speaker information
| Name | Position | Institution |
|---|---|---|
| Julien Grogg | CEO | Release Tx |
Host and event manager:
Logistics and marketing partner:
